| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 11.471 | 22.944 | 34.049 | 32.850 | 28.400 |
| Total Income - EUR | - | - | - | - | - | 12.348 | 22.944 | 34.049 | 32.850 | 28.400 |
| Total Expenses - EUR | - | - | - | - | - | 21.616 | 25.869 | 27.281 | 27.469 | 30.604 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -9.268 | -2.925 | 6.769 | 5.381 | -2.204 |
| Net Profit/Loss - EUR | - | - | - | - | - | -9.374 | -3.154 | 6.429 | 5.053 | -3.056 |
| Employees | - | - | - | - | - | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Fizio-Pro Dr.oprea S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 14.243 | 14.789 | 19.593 | 16.077 | 12.805 |
| Current Assets | - | - | - | - | - | 1.095 | 1.418 | 2.297 | 6.017 | 8.003 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 220 | 416 | 2.434 | 2.684 |
| Cash | - | - | - | - | - | 1.095 | 1.198 | 1.881 | 3.583 | 5.319 |
| Shareholders Funds | - | - | - | - | - | -9.332 | -12.280 | -5.889 | -819 | -3.870 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 24.671 | 28.486 | 27.780 | 22.913 | 24.678 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Fizio-Pro Dr.oprea S.r.l.